User profiles for "author:Padraig Dixon"

Padraig Dixon

Senior Researcher in Health Economics
Verified email at phc.ox.ac.uk
Cited by 870

[HTML][HTML] Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

P Dixon, E Keeney, JC Taylor, S Wordsworth… - Genetics in …, 2022 - Elsevier
Purpose Polygenic risk influences susceptibility to cancer. We assessed whether polygenic
risk scores could be used in conjunction with other predictors of future disease status in cost …

[HTML][HTML] Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention

C Salisbury, A O'Cathain, L Edwards… - The Lancet …, 2016 - thelancet.com
Background Many countries are exploring the potential of telehealth interventions to
manage the rising number of people with chronic disorders. However, evidence of the …

[PDF][PDF] The economics of intellectual property: a review to identify themes for future research

P Dixon, C Greenhalgh - CrIC, Manchester, 2002 - core.ac.uk
This paper reviews the literature on the economics of intellectual property rights. Intellectual
property rights (IPR) refer to the legal protection accorded to certain inventions or creations …

Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial

C Salisbury, A O'Cathain, C Thomas, L Edwards… - bmj, 2016 - bmj.com
Objective To assess whether non-clinical staff can effectively manage people at high risk of
cardiovascular disease using digital health technologies. Design Pragmatic, multicentre …

[HTML][HTML] Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study

S Harrison, P Dixon, HE Jones, AR Davies… - PLoS …, 2021 - journals.plos.org
Background The prevalence of obesity has increased in the United Kingdom, and reliably
measuring the impact on quality of life and the total healthcare cost from obesity is key to …

[HTML][HTML] Did it matter that the cancer drugs fund was not NICE? A retrospective review

P Dixon, C Chamberlain, W Hollingworth - Value in Health, 2016 - Elsevier
Abstract Background The Cancer Drugs Fund (CDF) will have spent more than£ 1 billion
between October 2010 and the introduction of reforms to its structure and operations in July …

[HTML][HTML] Mendelian Randomization analysis of the causal effect of adiposity on hospital costs

P Dixon, W Hollingworth, S Harrison, NM Davies… - Journal of Health …, 2020 - Elsevier
Estimates of the marginal effect of measures of adiposity such as body mass index (BMI) on
healthcare costs are important for the formulation and evaluation of policies targeting …

The causal effects of health conditions and risk factors on social and socioeconomic outcomes: Mendelian randomization in UK Biobank

S Harrison, AR Davies, M Dickson… - International Journal …, 2020 - academic.oup.com
Background We aimed to estimate the causal effect of health conditions and risk factors on
social and socioeconomic outcomes in UK Biobank. Evidence on socioeconomic impacts is …

[HTML][HTML] Quantifying the causal impact of biological risk factors on healthcare costs

J Lee, S Jukarainen, A Karvanen, P Dixon… - Nature …, 2023 - nature.com
Understanding the causal impact that clinical risk factors have on healthcare-related costs is
critical to evaluate healthcare interventions. Here, we used a genetically-informed design …

Feasibility cluster randomised controlled trial of a within-consultation intervention to reduce antibiotic prescribing for children presenting to primary care with acute …

PS Blair, S Turnbull, J Ingram, N Redmond, PJ Lucas… - BMJ open, 2017 - bmjopen.bmj.com
Objective To investigate recruitment and retention, data collection methods and the
acceptability of a 'within-consultation'complex intervention designed to reduce antibiotic …